effectiveness of mindfulness-based relapse prevention group therapy among people with opioids use disorder

Not Applicable

• Conditions: Opioids dependence.; Opioid dependence; F11.2

• Registration Number: IRCT20170702034844N5
• Lead Sponsor: Iranian National Center for Addiction Studies

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 18 May 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

age: 20 to 45 years old
education: at least 8 grades
opioids use disorder based on DSM-5 criteria
informed consent for participating in research
maitenance therapy with methadone or buprenorphine more than 1 week and less than 24 weeks

Exclusion Criteria

having psychotic syptoms
organic brain disorder
having suicide thoughts based on interiew
meeting critera for personality disorder

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Shame score other ad shamer scale. Timepoint: Before starting the treatment, after treatment, and 1 month after treatment. Method of measurement: Using other as shamer scale.;Scores in positive and negative perfectionism questionarre. Timepoint: Before starting the treatment, after treatment, and 1 month after treatment. Method of measurement: Using positive and negative perfectionism questionarre.;Scores in self-criticism questionarre. Timepoint: Before starting the treatment, after treatment, and 1 month after treatment. Method of measurement: Using self criticism questionarre.